The intermediate lobe of rodent pituitaries is involved in the regulation of prolactin (PRL) secretion from the anterior lobe. In a previous study, we demonstrated the stimulatory effect of α-melanocyte-stimulating hormone (α-MSH) on PRL release and the expression of melanocortin-3 receptors (MC3-Rs) in cultured mouse pituitary cells. The aim of the present study was to clarify whether α-MSH directly stimulates PRL release through the MC3-Rs by determining the cell type of MC3-R-expressing cells in the mouse pituitary anterior lobe. Northern blot analysis revealed a 2.7-kb transcript for MC3-R mRNA in the anterior and neurointermediate lobes of pituitary glands of adult male and female mice. Dual cellular localization of MC3-R mRNA and PRL or growth hormone (GH) in the mouse pituitary glands was performed by in situ hybridization analysis of MC3-R mRNA followed by immunocytochemical detection of PRL or GH. MC3-R mRNA was detected in most mammotropes and some somatotropes. α-MSH increased PRL release and stimulated DNA replication in mammotropes, and these effects were blocked by SHU9119, an antagonist of MC3-R and MC4-R. These results indicate that α-MSH stimulates PRL release and proliferation of mammotropes through MC3-Rs, and suggest that α-MSH from intermediate lobes can regulate mammotrope functions in the mouse pituitary.

Keywords:
Melanocyte-stimulating hormone, Melanocortin receptors, Prolactin, Lactotropes, Somatotropes, Mouse, Immunocytochemistry
1.
Ben-Jonathan N: Regulation of prolactin secretion; in Imura H (ed): The Pituitary Gland. New York, Raven Press, 1994, pp 261–283.
2.
Hill JB, Nagy GM, Frawley LS: Suckling unmasks the stimulatory effect of dopamine on prolactin release: Possible role for α-melanocyte-stimulating hormone as a mammotrope responsiveness factor. Endocrinology 1991;129:843–847.
3.
Hill JB, Lacy ER, Nagy GM, Gorcs TJ, Frawley LS: Does α-melanocyte-stimulating hormone from the pars intermedia regulate suckling-induced prolactin release? Supportive evidence from morphological and functional studies. Endocrinology 1993;133:2991–2997.
4.
Murai I, Ben-Jonathan N: Acute stimulation of prolactin release by estradiol: Mediation by the posterior pituitary. Endocrinology 1990;126:3179–3184.
5.
Ellerkmann E, Nagy GM, Frawley LS: Rapid augmentation of prolactin cell number and secretory capacity by an estrogen-induced factor released from the neurointermediate lobe. Endocrinology 1991;129:838–842.
6.
Ellerkmann E, Nagy GM, Frawley LS: α-Melanocyte-stimulating hormone is a mammotrophic factor released by neurointermediate lobe cells after estrogen treatment. Endocrinology 1992;130:133–138.
7.
Morooka Y, Oomizu S, Takeuchi S, Takahashi S: Augmentation of prolactin release by α-melanocyte-stimulating hormone is possibly mediated by melanocortin 3-receptors in the mouse anterior pituitary cells. Zool Sci 1998;15:567–572.
8.
Cone RD, Lu D, Koppula S, Vage DI, Klungland H, Boston B, Chen W, Orth DN, Pouton C, Kesterson RA: The melanocortin receptors: Agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res 1996;51:287–317.
9.
Roudbaraki M, Lorsignol A, Langouche L, Callewaert G, Vankelecom H, Denef C: Target cells of γ3-melanocyte-stimulating hormone detected through intracellular Ca2+ responses in immature rat pituitary constitute a fraction of all main pituitary cell types, but mostly express multiple hormone phenotypes at the messenger ribonucleic acid level. Refractoriness to melanocortin-3 receptor blockade in the lacto-somatotroph lineage. Endocrinology 1999;140:4874–4885.
10.
Takahashi S, Kawashima S: Proliferation of prolactin cells in the rat: Effects of estrogen and bromocryptine. Zool Sci 1987;4:855–860.
11.
Hruby VJ, Lu D, Sharma SD, Castrucci AL, Kesterson RA, al-Obeidi FA, Hadley ME, Cone RD: Cyclic lactam α-melanotropin analogues of Ac-N1e4-cyclo [Asp5, D-Phe7,Lys10] α-melanocyte-stimulating hormone-(4–10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem 1995;38:3454–3461.
12.
Schioth HB, Muceniece R, Mutulis F, Bouifrouri AA, Mutule I, Wikberg JE: Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014:Comparison with SHU9119. Neuropeptides 1999;33:191–196.
13.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–159.
14.
Takeuchi S, Takahashi S: A possible involvement of melanocortin 3 receptor in the regulation of adrenal gland function in the chicken. Biochim Biophys Acta 1999;1448:512–518.
15.
Takahashi S: Growth hormone secretion in old female rats analyzed by the reverse hemolytic plaque assay. Acta Endocrinol 1992;127:531–535.
16.
Honda J, Oomizu S, Kiuchi Y, Komatsu N, Takeuchi S, Takahashi S: Identification of epidermal growth factor mRNA-expressing cells in the mouse anterior pituitary. Neuroendocrinology 2000;71:155–162.
17.
Oomizu S, Takahashi S: Insulin stimulates the proliferation of mouse anterior pituitary cells in vitro. Biomed Res 1996;17:365–371.
18.
Oomizu S, Takeuchi S, Takahashi S: Stimulatory effect of insulin-like growth factor I on proliferation of mouse pituitary cells in serum-free culture. J Endocrinol 1998;157:53–62.
19.
Hsu SM, Soban E: Color modification of diaminobenzidine precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem 1982;30:1079–1082.
20.
Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577–580.
21.
Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD: Identification of a receptor for α-melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 1993;90:8856–8860.
22.
Desarnaud F, Labbé O, Eggerickx D, Vassart G, Parmentier M: Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene. Biochem J 1994;299:367–373.
23.
Takahashi S: Development and heterogeneity of prolactin cells. Int Rev Cytol 1995;157:33–98.
24.
Zheng T, Villalobos C, Nusser KD, Gettys TW, Faught WJ, Castaña JP, Frawley LS: Phenotypic characterization and functional correlation of α-MSH binding to pituitary cells. Am J Physiol 1997;272:E282–E287.
25.
Nuñez L, Frawley LS: α-MSH potentiates the responsiveness of mammotropes by increasing Ca2+ entry. Am J Physiol 1998;274:E971–E977.
26.
Ellerkmann E, Porter TE, Nagy GM, Frawley LS: N-acetylation is required for the lactotrope recruitment activity of α-melanocyte-stimulating hormone and β-endorphin. Endocrinology 1992;131:566–570.
27.
Laudon M, Grossman DA, Ben-Jonathan N: Prolactin-releasing factor: Cellular origin in the intermediate lobe of the pituitary. Endocrinology 1990;126:3185–3192.
28.
Allen DL, Low MJ, Allen RG, Ben-Jonathan N: Identification of two classes of prolactin-releasing factors in intermediate lobe tumors from transgenic mice. Endocrinology 1995;136:3093–3099.
29.
Lindley SE, Gunnet JW, Lookingland KJ, Moore KE: Effects of alterations in the activity of tuberohypophysial dopaminergic neurons on the secretion of α-melanocyte-stimulating hormone. Proc Soc Exp Biol Med 1988;188:282–286.
30.
Benjannet S, Rondeau N, Day R, Chrétien M, Seidah NG: PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA 1991;88:3564–3568.
31.
Marcinkiewicz M, Day R, Seidah NG, Chretien M: Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and α-melanotropin. Proc Natl Acad Sci USA 1993;90:4922–4926.
32.
Nagy GM, Boockfor FR, Frawley LS: The suckling stimulus increases the responsiveness of mammotropes located exclusively within the central region of the adenohypophysis. Endocrinology 1991;128:761–764.
33.
Porter TE, Frawley LS: Neurointermediate lobe peptides recruit prolactin-secreting cells exclusively within the central region of the adenohypophysis. Endocrinology 1992;131:2649–2652.
34.
Murakami T, Ohtsuka A, Taguchi T, Kikuta A, Ohtani O: Blood vascular bed of the rat pituitary intermediate lobe, with special reference to its development and portal drainage into the anterior lobe. A scanning electron microscope study of vascular casts. Arch Histol Jpn 1985;48:69–87.
35.
Tilemans D, Ramaekers D, Andries M, Denef C: Effect of POMC1–76, its C-terminal fragment γ3-MSH and anti-POMC1–76 antibodies on DNA replication in lactotrophs in aggregate cell cultures of immature rat pituitary. J Neuroendocrinol 1997;9:627–637.
36.
Bert C, Vande Vijver V, Andries M, Verhaert P, Proost P, De Vreese B, Van Beeumen J, Vankelecom H, Denef C: Production of recombinant rat proopiomelanocortin 1–74 and characterization of its mitogenic action on pituitary lactotrophs. Mol Cell Endocrinol 1999;154:111–122.
37.
Langouche L, Roudbaraki M, Pals K, Denef C: Stimulation of intracellular free calcium in GH3 cells by γ3-melanocyte-stimulating hormone. Involvement of a novel melanocortin receptor? Endocrinology 2001;142:257–266.
38.
Langouche L, Pals K, Denef C: Structure-activity relationship and signal transduction of γ-MSH peptides in GH3 cells: Further evidence for a new melanocortin receptor. Peptides 2002;23:1077–1086.
39.
Oomizu S, Honda J, Takeuchi S, Kakeya T, Masui T, Takahashi S: Transforming growth factor-α stimulates proliferation of mammotrophs and corticotrophs in the mouse pituitary. J Endocrinol 2000;165:493–501.
40.
Denef C: Paracrine mechanisms in the pituitary; in Imura H (ed): The Pituitary Gland. New York, Raven Press, 1994, pp 351–378.
41.
Schwartz J: Intercellular communication in the anterior pituitary. Endocr Rev 2000;21:488–513.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.